Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Efficacy, Safety & Tolerability of Ciclesonide 200mcg Spray 4 Weeks Treatment for Intermittent & Persistent Rhinitis (SISRIP)
This study has been completed.
Study NCT01369563 Information provided by Takeda Global Research & Development Center, Inc.
First Received on June 7, 2011. Last Updated on September 14, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Respiratory Tract Diseases
Respiratory Tract Infections
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial
Takeda México S.A. de C.V.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers